Avid Bioservices (NASDAQ:CDMO) Earns Overweight Rating from Stephens
Avid Bioservices (NASDAQ:CDMO – Get Free Report)‘s stock had its “overweight” rating reiterated by equities research analysts at Stephens in a research note issued to investors on Tuesday, Benzinga reports. They presently have a $12.00 price objective on the biopharmaceutical company’s stock. Stephens’ price objective points to a potential upside of 15.38% from the stock’s […]
More Stories
US Signs Critical Minerals, Energy, Technology Deals With Finland, Hungary
By Victoria Friedman The United States has signed critical mineral, energy, and technology deals with Finland and Hungary, strengthening economic...
Israel Heads for Coalition Talks After Election Deadlock
By Evgenia Filimianova Final Israeli election results showed that neither Prime Minister Benjamin Netanyahu nor his main rival, Gadi Eisenkot,...
Nasdaq Falls More Than 2 Percent as Amazon, Intel Earnings Weigh on Markets
By Andrew Moran The tech-heavy Nasdaq Composite Index fell more than 2 percent as disappointing results from Amazon and weak...
Oil Prices Jump Amid More Shipping Incidents in Strait of Hormuz
By Evgenia Filimianova Oil prices rose on Friday and were on track for sharp monthly gains after fresh maritime security...
State Official Says No System to Identify Whether Voters Are Noncitizens
By Zachary Stieber A top Washington state official said on Oct. 29 that the state has no way to confirm...
The Great Banking Betrayal: Who Really Paid the Price?
By Stephen Zogopoulos, USNN World News USNN WORLD NEWS | SPECIAL EDITORIAL INVESTIGATION October 30, 2026 | Investigative Opinion &...